| ￥3000 | |
| Z04326-100 | |
|
|
|
|
|
|
|
|
|
| Species | Mouse | ||||
| Protein Construction |
|
||||
| Purity | > 95% as determined by BisTris PAGE | ||||
| Endotoxin Level | Less than 1EU per μg by the LAL method. | ||||
| Expression System | HEK293 | ||||
| Theoretical Molecular Weight | 35.17 kDa | ||||
| Apparent Molecular Weight | Due to glycosylation, the protein migrates to 43-53 kDa based on Bis-Tris PAGE result. | ||||
| Formulation | Supplied as 0.22μm filtered solution in PBS (pH 7.4). | ||||
| Concentration | Verified by one or more methods from A280/Bioactivity/BCA/Bradford. | ||||
| Storage & Stability | This product remains stable for 6 months at -80°C or below. Avoid repeated freeze-thaw cycles. |
| Target Background | a CD59a fusion protein bound specifically to mouse B cells, and enhanced B cell proliferation in a MLR, demonstrating that B cells express an as yet unidentified ligand for CD59a that aids in B cell activation. |
| Synonyms | CD59A glycoprotein;CD59a antigen; MAC-inhibitory; MAC-IP; MACIP; Membrane attack complex inhibition factor; MACIF; Protectin; CD_antigen: CD59 |
For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.
